Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Iain Miller, Joseph Slattery


Iain Miller has established Healthcare Strategies Group, a London-based organization that provides strategic advisory services to life sciences tools firms and pharmaceutical companies.

Miller is involved in several international policy initiatives, including The European Personalized Medicine association, where he serves as a board member.

Previously, Miller worked at GE Healthcare as the global head of personalized healthcare strategy and partnerships. While at BioMerieux, Miller was senior director of oncology strategy and theranostics, and led strategy and business development activities within the company's personalized medicine business unit.

Exosome Diagnostics has appointed Joseph Slattery to its board of directors.

Slattery is CFO and executive VP of Baxano Surgical. Prior to Baxano, Slattery was CFO and senior VP of the molecular diagnostics firm Digene.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.